INVO Fertility, Inc. Investment Income, Net
INVO Fertility, Inc. (IVF) reported Investment Income, Net of $308 for the 12-month period ending 2022-12-31, per its 10-K/A filed 2024-11-19.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2024-11-19
- INVO Fertility, Inc. investment income, net for the quarter ending 2022-12-31 was $1.00, a 98.39% decline year-over-year.
- INVO Fertility, Inc. investment income, net for the quarter ending 2022-09-30 was $34.00.
- INVO Fertility, Inc. investment income, net for the quarter ending 2022-06-30 was $48.00, a 98.02% decline year-over-year.
- INVO Fertility, Inc. investment income, net for the quarter ending 2022-03-31 was $225.00, a 88.82% decline year-over-year.
- INVO Fertility, Inc. investment income, net for fiscal 2022 was $308.00, a 91.58% decline from fiscal 2021.
- INVO Fertility, Inc. investment income, net for fiscal 2021 was $3.66K, a 12.72% decline from fiscal 2020.
- INVO Fertility, Inc. investment income, net for fiscal 2020 was $4.19K.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2022-12-31 | $1.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-19 | $35.00 derived: sum of 2 quarters · filed 2024-11-19 | $83.00 derived: sum of 3 quarters · filed 2024-11-19 | $308.00 10-K/A · filed 2024-11-19 |
| 2022-09-30 | $34.00 10-Q · filed 2023-11-13 | $82.00 derived: sum of 2 quarters · filed 2023-11-13 | $307.00 10-Q · filed 2023-11-13 | $369.00 derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $48.00 10-Q · filed 2023-08-14 | $273.00 10-Q · filed 2023-08-14 | $335.00 derived: sum of 3 quarters · filed 2023-08-14 | -$508.00 derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $225.00 10-Q · filed 2023-05-15 | $287.00 derived: sum of 2 quarters · filed 2023-05-15 | -$556.00 derived: sum of 3 quarters · filed 2023-05-15 | $1.87K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $62.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$781.00 derived: sum of 2 quarters · filed 2023-04-17 | $1.64K derived: sum of 3 quarters · filed 2023-04-17 | $3.66K 10-K · filed 2023-04-17 |
| 2021-09-30 | -$843.00 10-Q · filed 2022-11-14 | $1.58K derived: sum of 2 quarters · filed 2022-11-14 | $3.60K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $2.42K 10-Q · filed 2022-08-15 | $4.44K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $2.01K 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $4.19K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |